ADPT
$24.42+1.96%
Adaptive Biotechnologies CorporationStock · HealthcareRussell 2000 · 0.1% of IWMNasdaq Composite · 0.006% of ONEQRussell 3000 · 0.005% of IWVUS Stock Market · 0.005% of VTI
ADPT financial statements
The full income statement, balance sheet, and cash-flow statement for Adaptive Biotechnologies Corporation (ADPT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 147.5M2024-09 147.6M2024-12 148.6M2025-03 151.9M2025-06 152.3M2025-09 152.7M2025-12 154.0M2026-03 160.0M2026-06 159.6M+8.2% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 277M+54.8% | 179M+5.1% | 170M-8.1% | 185M+20.1% | 154M+56.9% | |
| Cost of revenue | 71.4M-1.0% | 72.1M-4.6% | 75.6M+30.5% | 57.9M+17.5% | 49.3M+118.8% | |
| Research & development | 93.8M-8.9% | 103M-15.7% | 122M-13.9% | 142M-0.4% | 142M+22.6% | |
| Selling, general & administrative | 72.7M-0.1% | 72.8M-13.3% | 83.9M-5.2% | 88.5M+18.8% | 74.5M+50.4% | |
| General & administrative | 72.7M-0.1% | 72.8M-13.3% | 83.9M-5.2% | 88.5M+18.8% | 74.5M+50.4% | |
| Selling & marketing | 94.6M+11.6% | 84.8M-4.3% | 88.6M-7.3% | 95.6M+0.1% | 95.5M+55.6% | |
| Restructuring | — | 2.00M | — | 2.02M | — | |
| Amortization of intangibles | 1.70M-0.2% | 1.70M+0.2% | 1.70M+0.0% | 1.70M+0.0% | 1.70M-0.2% | |
| Operating income | -57.1M+64.9% | -163M+28.4% | -227M-13.4% | -200M+4.2% | -209M-36.7% | |
| Interest expense | 11.8M+1.7% | 11.6M-16.1% | 13.8M+225.6% | 4.24M | — | |
| Pre-tax income | -59.5M+62.7% | -160M+29.2% | -225M-12.4% | -200M+3.3% | -207M-41.8% | |
| Income tax | 0.00 | 0.00 | 0.00 | — | — | |
| -59.5M+62.7% | -159M+29.2% | -225M-12.5% | -200M+3.4% | -207M-41.8% | ||
| Net income to non-controlling interest | 42.0K+140.8% | -103K-90.7% | -54.0K+69.5% | -177K-831.6% | -19.0K | |
| Net income to common | — | — | — | — | -207M-41.8% | |
| -$0.39+63.9% | -$1.08+30.8% | -$1.56-11.4% | -$1.40+5.4% | -$1.48-33.3% | ||
| EPS (basic) | -$0.39+63.9% | -$1.08+30.8% | -$1.56-11.4% | -$1.40+5.4% | -$1.48-33.3% | |
| Weighted-avg shares (basic) | 152M+3.1% | 147M+1.9% | 144M+1.3% | 143M+1.5% | 140M+7.0% | |
| Weighted-avg shares (diluted) | 152M+3.1% | 147M+1.9% | 144M+1.3% | 143M+1.5% | 140M+7.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 300M+5.8% | 284M-30.8% | 410M-27.0% | 562M+39.6% | 403M-44.6% | ||
| Cash & equivalents | 70.5M+47.1% | 47.9M-26.3% | 65.1M-27.7% | 90.0M-35.3% | 139M+12.7% | |
| Accounts receivable | 50.4M+20.7% | 41.7M+9.9% | 38.0M-5.2% | 40.1M+130.1% | 17.4M+73.3% | |
| Inventory | 9.82M+16.4% | 8.44M-41.6% | 14.4M-0.0% | 14.5M-25.0% | 19.3M+37.0% | |
| Prepaid expenses | 13.0M+15.4% | 11.3M-0.7% | 11.4M+20.4% | 9.44M-27.5% | 13.0M-10.5% | |
| 513M-4.9% | 539M-18.4% | 661M-22.8% | 857M-7.2% | 923M-17.3% | ||
| Property, plant & equipment | 34.1M-29.8% | 48.6M-28.7% | 68.2M-18.2% | 83.4M-2.1% | 85.3M+114.8% | |
| Operating lease right-of-use | 40.6M-11.3% | 45.8M-12.1% | 52.1M-35.5% | 80.8M-7.9% | 87.7M-11.7% | |
| Goodwill | 119M+0.0% | 119M+0.0% | 119M+0.0% | 119M+0.0% | 119M+0.0% | |
| Intangible assets | 1.73M-49.6% | 3.42M-33.2% | 5.13M-24.9% | 6.83M-19.9% | 8.53M-16.6% | |
| Other non-current assets | 1.21M-47.2% | 2.29M-36.3% | 3.59M+74.0% | 2.06M+135.9% | 875K+46.3% | |
| 89.9M-8.3% | 98.1M+11.4% | 88.0M-19.8% | 110M-3.5% | 114M+8.2% | ||
| Accounts payable | 6.47M-11.0% | 7.26M-5.9% | 7.72M-4.5% | 8.08M+144.5% | 3.31M+2.2% | |
| Accrued liabilities | 7.70M-5.6% | 8.16M-5.1% | 8.60M-30.8% | 12.4M+33.0% | 9.34M-29.0% | |
| Deferred revenue | 45.2M-18.8% | 55.7M+14.5% | 48.6M-24.2% | 64.1M-20.3% | 80.5M+9.7% | |
| Short-term & current debt | 4.64M+436.6% | 865K | — | — | — | |
| Current lease liability | 8.92M-12.9% | 10.2M+9.1% | 9.38M+1.7% | 9.23M+82.6% | 5.05M+43.2% | |
| 288M-14.6% | 337M-4.5% | 353M-10.1% | 393M+23.0% | 319M-14.4% | ||
| Long-term debt | 127M-4.4% | 132M+1.3% | 131M+4.2% | 125M | — | |
| Deferred revenue (non-current) | 1.01M-96.3% | 27.3M-39.2% | 44.8M-23.6% | 58.6M-40.7% | 98.8M-39.6% | |
| Non-current lease liability | 70.2M-11.3% | 79.1M-11.5% | 89.4M-9.5% | 98.8M-7.4% | 107M+2.3% | |
| Operating lease liability (total) | 79.1M-11.5% | 89.4M-9.5% | 98.8M-8.5% | 108M-3.3% | 112M+3.6% | |
| Other non-current liabilities | 20.0K+0.0% | 20.0K | — | — | — | |
| 219M+7.9% | 203M-34.3% | 308M-33.6% | 464M-23.2% | 604M-18.7% | ||
| Common stock | 15.0K+7.1% | 14.0K+0.0% | 14.0K+0.0% | 14.0K+0.0% | 14.0K+0.0% | |
| Additional paid-in capital | 1.58B+5.0% | 1.51B+3.7% | 1.45B+4.7% | 1.39B+4.8% | 1.32B+5.6% | |
| Retained earnings | -1.36B-4.6% | -1.30B-13.9% | -1.14B-24.5% | -919M-27.8% | -719M-40.5% | |
| Accumulated other comprehensive income | 253K+52.4% | 166K-22.8% | 215K+105.2% | -4.12M-262.0% | -1.14M-227.3% | |
| Non-controlling interest | 6.21M+2871.4% | -224K-85.1% | -121K-80.6% | -67.0K-160.9% | 110K | |
| Total equity incl. non-controlling | 225M+11.1% | 202M-34.3% | 308M-33.6% | 464M-23.2% | 604M-18.7% | |
| Total liabilities & equity | 513M-4.9% | 539M-18.4% | 661M-22.8% | 857M-7.2% | 923M-17.3% | |
| Common shares issued | 154M+4.1% | 148M+1.9% | 145M+1.4% | 143M+1.2% | 141M+2.7% | |
| Common shares outstanding | 154M+4.1% | 148M+1.9% | 145M+1.4% | 143M+1.2% | 141M+2.7% | |
| Shares outstanding (cover) | 154M+3.6% | 149M+2.4% | 145M+1.3% | 143M+1.2% | 142M+1.7% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -46.0M+51.7% | -95.2M+39.1% | -156M+15.0% | -184M+4.6% | -193M-28.8% | ||
| Depreciation & amortization | 16.0M-8.3% | 17.4M-11.0% | 19.6M-6.3% | 20.9M+49.9% | 14.0M+64.7% | |
| Intangible amortization | 1.70M-0.2% | 1.70M+0.2% | 1.70M+0.0% | 1.70M+0.0% | 1.70M-0.2% | |
| Share-based compensation | 51.5M-4.0% | 53.6M-14.8% | 62.9M+13.4% | 55.5M+28.3% | 43.3M+74.7% | |
| Change in receivables | 8.65M+130.9% | 3.74M+284.3% | -2.03M-109.0% | 22.6M+207.6% | 7.36M+381.7% | |
| Change in inventory | 998K+118.6% | -5.37M-289.3% | 2.84M+447.4% | -817K-115.7% | 5.20M+4.1% | |
| 38.0M-51.2% | 77.8M-40.0% | 130M+4362.9% | 2.90M-98.4% | 181M+254.8% | ||
| Capital expenditure | 2.96M-19.2% | 3.66M-65.7% | 10.7M-34.6% | 16.3M-73.5% | 61.7M+228.4% | |
| Free cash flow | -48.9M+50.5% | -98.9M+40.8% | -167M+16.6% | -200M+21.3% | -254M-51.0% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 30.4M+12515.4% | 241K-89.3% | 2.25M-98.3% | 132M+387.2% | 27.1M-90.8% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 22.4M+230.2% | -17.2M+29.7% | -24.4M+49.9% | -48.8M-412.1% | 15.6M-41.8% | |
| Interest paid | 12.6M+42.6% | 8.86M-1.3% | 8.98M+1718.8% | 494K | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 2.50B+180.7% | 891M+25.6% | 709M-35.1% | 1.09B-72.5% | 3.97B-51.7% | |
| P/S | 9.0×+81.4% | 5.0×+26.1% | 3.9×-39.3% | 6.5×-74.7% | 25.7×-69.2% | |
| P/B | 11.4×+160.1% | 4.4×+124.1% | 2.0×-12.4% | 2.2×-65.9% | 6.6×-40.6% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ADPT’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ADPT filings on SEC EDGAR → Not investment advice.